1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow MDR-TB: new trials by email Literature Review of MDR-TB trials Research Report on MDR-TB
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine - MDR-TB | Phase 3 | Completed | IUATLD, Inc | 588 | 2016-03-01 | 2023-09-28 |
Tuberculosis, Multidrug-Resistant (1)
Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Mycobacterium Infections (1) · Tuberculosis (1)
Clofazimine (1) · Ethambutol (1) · Isoniazid (1) · Kanamycin (1) · Levofloxacin (1) · Moxifloxacin (1) · Prothionamide (1) · Pyrazinamide (1) · bedaquiline (1)
IUATLD, Inc (1)
Ethiopia (1) · Georgia (1) · India (1) · Moldova (1) · Mongolia (1) · South Africa (1) · Uganda (1)
Andrew Nunn, PhD (1) · Sarah Meredith, MD (1)